Black Cohosh - Non-Timber Forest Products
Black Cohosh - Non-Timber Forest Products
Black Cohosh - Non-Timber Forest Products
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
metastasis of cancer to the lungs was higher in groups taking black cohosh<br />
(27.1 percent, n = 96 treatment group, versus 10.9 percent, n = 110, control<br />
group) after 14 weeks of treatment. The number of lung tumors increased<br />
with longer exposure to black cohosh. The results indicated that black<br />
cohosh did not increase the possibility of developing breast cancer in<br />
healthy individuals, but could accelerate metastasis of existing tumors.<br />
Keywords: Cancer, clinical studies.<br />
Dixon-Shanies, D.; Shaikh, N. 1999. Growth inhibition of human breast<br />
cancer cells by herbs and phytoestrogens. Oncology Reports. 6: 1383–<br />
1387.<br />
Evaluates the abilities of various agents to protect against breast cancer.<br />
<strong>Black</strong> cohosh extract was found to inhibit growth of T–47D cancer cells.<br />
Keywords: Cancer, clinical studies, phytoestrogens, research.<br />
Dog, T.L.; Powell, K.L.; Weisman, S.M. 2003. Critical evaluation of<br />
the safety of Cimicifuga racemosa in menopause symptom relief.<br />
Menopause. 10(40): 299-313.<br />
Reviews clinical research on the safety of black cohosh for treating<br />
menopausal symptoms. Reports from both the U.S. Food and Drug<br />
Administration, Special Nutritional Adverse Events Monitoring System and<br />
the World Health Organization Collaborating Center for International Drug<br />
Monitoring are presented. Adverse effects reported included headache, high<br />
blood pressure, heart attack, diarrhea, chest pain, anxiety, and weakness.<br />
In most cases, the patients used a combination product that contained<br />
black cohosh and other herbs. The products named in the report were not<br />
investigated, and the cause of the reaction only speculated. A postmarketing<br />
survey conducted by the manufacturers of Remifemin ® found that 7 percent<br />
of patients experienced temporary, mild gastrointestinal upset. No serious<br />
side effects were reported. Numerous clinical studies on the effect of black<br />
cohosh in vivo and in vitro are reviewed. These studies suggested that<br />
black cohosh is safe when used in the recommended dosage for a period<br />
of 6 months and possibly longer. Studies on black cohosh and estrogen<br />
receptor-positive breast cancer showed that black cohosh did not stimulate<br />
cell proliferation, and may have actually inhibited the development of<br />
tumors. The authors concluded that the long history of medicinal usage, low<br />
incidence of adverse effects, and numerous clinical studies demonstrating<br />
improvement in menopausal symptoms with a lack of serious side effects<br />
35